Skip to content

The demonstration and promotion of traditional chinese medicine clinical guidelines for lung cancer-- the effect evaluation of rehabilitation cream formula on postoperative non-small cell lung cancer patients.

The demonstration and promotion of traditional chinese medicine clinical guidelines for lung cancer-- the effect evaluation of rehabilitation cream formula on postoperative non-small cell lung cancer patients.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-14005401
Enrollment
Unknown
Registered
2014-09-01
Start date
2014-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NSCLC

Interventions

research group:rehabilitation cream formula

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Non-small cell lung cancer patients diagnosed by pathology or cytology; (2) Postoperative II - IIIA period patients completed 3-4 months' postoperative adjuvant treatment; (3) Conform to the deficiency syndrome of traditional Chinese medicine (qi deficiency, blood deficiency, Yin deficiency and Yang deficiency) diagnostic criteria of the patients ; (4) ECOG(Eastern Cooperative Oncology Group performance status): 0-1, KPS(Karnofsky Performance Status): 80-100; (5) The Prediction of the Survival Time longer than at least 6 months; (6) Aged 18 to 75 years old; (7) Sign a consent form and have a good compliance.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women, psychopaths; (2) Patients with serious, uncontrolled organic diseases or infections, such as the decompensated heart, lung, and kidney failure that cannot tolerate the chemotherapy; (3) In other clinical trials; (4) Patients allergic to research medicines.

Design outcomes

Primary

MeasureTime frame
clinical symptoms;QOL (quality of life);DFS (disease-free survival);TCM curative effection of deficiency syndrome;

Secondary

MeasureTime frame
weight;KPS/ECOG;immunologic function;tumor markers;

Countries

China

Contacts

Public ContactLin Hongsheng
drlinhongsheng@163.com+86 010-88001192

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026